0 items USD 0.00Search
- Did you mean
- fibrosis drug
Your search for "sclerosis drug" gave back 75886 results.
The global Targeted Drugs for Multiple Sclerosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing...
颁补迟补濒辞驳:听
MRRPB5
August 2024
Price: USD 2,900.00
Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig鈥檚 disease or Maladie De Charcot, it is a neurological disease that causes nerve cells...
颁补迟补濒辞驳:听
MRRPB5
February 2023
Price: USD 2,900.00
Systemic Sclerosis (Scleroderma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets...
颁补迟补濒辞驳:听
Global Markets Direct
March 2022
Price: USD 2,500.00
Multiple Sclerosis (Central Nervous System) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
颁补迟补濒辞驳:听
Global Markets Direct
November 2021
Price: USD 2,500.00
The global Multiple Sclerosis Therapies market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030...
颁补迟补濒辞驳:听
GIR
October 2024
Price: USD 3,480.00
Systemic Sclerosis (Scleroderma) (Immunology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
颁补迟补濒辞驳:听
Global Markets Direct
March 2021
Price: USD 2,500.00
Amyotrophic Lateral Sclerosis (Central Nervous System) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and...
颁补迟补濒辞驳:听
Global Markets Direct
September 2021
Price: USD 2,500.00
Systemic sclerosis is a rare but serious autoimmune disease which causes hardening and swelling of the skin, as well as joint pain, digestive...
颁补迟补濒辞驳:听
MRRPB5
December 2024
Price: USD 4,900.00
Tuberous Sclerosis (Genetic Disorders) - Drugs in Development, 2021 Summary Tuberous Sclerosis (Genetic Disorders) - Drugs in Development, 2021...
颁补迟补濒辞驳:听
Global Markets Direct
April 2021
Price: USD 2,000.00
Systemic sclerosis is a rare but serious autoimmune disease which causes hardening and swelling of the skin, as well as joint pain, digestive...
颁补迟补濒辞驳:听
MRRPB5
May 2024
Price: USD 2,900.00
Tuberous Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Tuberous Sclerosis Drugs in Development by...
颁补迟补濒辞驳:听
Global Markets Direct
May 2022
Price: USD 2,000.00
Relapsing Multiple Sclerosis (RMS) (Central Nervous System) - Drugs in Development, 2021 Summary Relapsing Multiple Sclerosis (RMS) (Central Nervous...
颁补迟补濒辞驳:听
Global Markets Direct
April 2021
Price: USD 2,000.00
Secondary Progressive Multiple Sclerosis (SPMS) (Central Nervous System) - Drugs in Development, 2021 Summary Secondary Progressive Multiple...
颁补迟补濒辞驳:听
Global Markets Direct
April 2021
Price: USD 2,000.00
Relapsing Remitting Multiple Sclerosis (RRMS) (Central Nervous System) - Drugs in Development, 2021 Summary Relapsing Remitting Multiple Sclerosis (...
颁补迟补濒辞驳:听
Global Markets Direct
April 2021
Price: USD 2,000.00
Primary Progressive Multiple Sclerosis (PPMS) (Central Nervous System) - Drugs in Development, 2021 Summary Primary Progressive Multiple Sclerosis (...
颁补迟补濒辞驳:听
Global Markets Direct
April 2021
Price: USD 2,000.00
听
